⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

December 27, 2005Leukemia & lymphoma/Leukemia and lymphoma

Aggressive non-Hodgkin's lymphoma: Concomitant evaluation of interleukin-2, soluble interleukin-2 receptor, interleukin-4, interleukin-6, interleukin-10 and correlation with outcome

View Full Paper

Ask AI

Bookmark

Share

Authors

EFElizabeth Fabre-Guillevin RTReza TabriziCentre Hospitalier Universitaire de Besançon VCValérie CoulonInstitut Bergonié

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Fabre-Guillevin et al. (2005) studied this question.

synapsesocial.com/papers/6a8c10b52ff0ab4f91e9643d https://doi.org/10.1080/10428190500361029

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

1Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome2001 · 290 citations
2Prognostic value of serum IL‐10 and soluble IL‐2 receptor levels in aggressive non‐Hodgkin's lymphoma1994 · 50 citations